Under which realistic circumstances is hrHPV self‐sampling increasing cervical screening effectiveness in a partly vaccinated population? A modelling study
International Journal of Cancer · 2026
DOI: 10.1002/ijc.70184 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, 2026. Verfasst von Sylvia Kaljouw und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Papillomavirus Infections, Early Detection of Cancer, Self Care. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Dutch National Institute for Public Health and the Environment.
Abstract (Originalsprache)
High‐risk Human Papillomavirus self‐sampling can increase attendance rates for screening. However, observed lower sensitivity and loss to follow‐up of self‐sampling could reduce programme effectiveness when attenders of clinician‐collected sampling switch to self‐sampling. We determined the tipping point for effectiveness (based on life years gained [LYG]) of self‐sampling and the consequences for cost‐effectiveness, taking into account waste by comparing full opt‐out (no waste) to no opt‐out (waste from unused self‐sampling kits). We used the STDSIM‐MISCAN‐Cervix microsimulation model to simulate a population of Dutch women born in 2000 (50% vaccinated [sensitivity analysis: 0–100%], 70% screening attendance [sensitivity analysis: 60–80%]). Self‐sampling deployment strategies (e.g., direct‐mail) were varied by the percentage of original attenders switching to self‐sampling and the percentage of new attendance from non‐attenders. Main outcome measures were LYG and cost‐effectiveness (cost per quality adjusted [QA] LY gained) compared to the current programme. We found that if self‐sampling does not reach non‐attenders, life years cannot be gained. When reaching 10% or 30% of non‐attenders, the tipping point lies at ≤40% and ≤100% switchers to maintain effectiveness, respectively (+4 LYG, +10 LYG). Scenarios were cost‐effective (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
- Heidelberg Institute of Global Health, Universitätsklinikum Heidelberg, Heidelberg, Germany.
ORCID-Profile: Sylvia Kaljouw, Erik E L Jansen, Ellen M G Olthof, Jan A C Hontelez, Inge M C M de Kok
Förderung
- Dutch National Institute for Public Health and the Environment
Zitieren
APA
Kaljouw, S., Jansen, E. E. L., Olthof, E. M. G., Hontelez, J. A. C., & de Kok, I. M. C. M. (2026). Under which realistic circumstances is hrHPV self‐sampling increasing cervical screening effectiveness in a partly vaccinated population? A modelling study. International Journal of Cancer. https://doi.org/10.1002/ijc.70184
Vancouver
Kaljouw S, Jansen EEL, Olthof EMG, Hontelez JAC, de Kok IMCM. Under which realistic circumstances is hrHPV self‐sampling increasing cervical screening effectiveness in a partly vaccinated population? A modelling study. International Journal of Cancer. 2026. doi:10.1002/ijc.70184
BibTeX
@article{Kaljouw2026,
author = {Kaljouw, Sylvia and Jansen, Erik E L and Olthof, Ellen M G and Hontelez, Jan A C and de Kok, Inge M C M},
title = {Under which realistic circumstances is hrHPV self‐sampling increasing cervical screening effectiveness in a partly vaccinated population? A modelling study},
journal = {International Journal of Cancer},
year = {2026},
doi = {10.1002/ijc.70184}
}
EUVIMED